Cardiovascular Devices companies

Key Cardiovascular Devices Market Players:

Below is the list of some prominent players operating in the global cardiovascular devices market:

• Medtronic plc (Ireland)
• Abbott Laboratories (U.S.)
• Boston Scientific Corporation (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• Johnson & Johnson MedTech (U.S.)
• GE Healthcare Technologies, Inc. (U.S.)
• Baxter International Inc. (U.S.)
• W. L. Gore & Associates, Inc. (U.S.)
• Terumo Corporation (Japan)
• Nihon Kohden Corporation (Japan)
• Japan Lifeline Co., Ltd. (Japan)
• Siemens Healthineers AG (Germany)
• Koninklijke Philips N.V. (Netherlands)
• B. Braun SE (Germany)
• BIOTRONIK SE & Co. KG (Germany)
• Getinge AB (Sweden)
• Impulse Dynamics (U.S.)
• CathWorks (Israel)
• LivaNova PLC (UK)
• Sahajanand Medical Technologies Limited (India)
• BPL Medical Technologies (India)
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis

The cardiovascular devices market is being intensely dominated by multinational players, which have extensive product portfolios and strong R&D capabilities. Leading companies in this field are highly focused on innovation in minimally invasive technologies, such as transcatheter valves and pulsed-field ablation, with the main goal to improve patient outcomes. Mergers and acquisitions to expand product portfolios and geographic reach are certain expansion strategies adopted by companies in this sector.  At the same time, firms are also proactively making investments in digital health, AI integration, and remote monitoring solutions. Partnerships with hospitals and expansion in emerging markets effectively strengthen market presence. In February 2026, Medtronic plc announced its intent to acquire CathWorks for up to USD 585 million to strengthen its cardiovascular portfolio through AI-based innovation. This particular deal builds on their 2022 partnership and focuses on expanding the adoption of the FFRangioSystem, which enables non-invasive, angiography-based coronary assessment.

Corporate Landscape of the Cardiovascular Devices Market:

• Medtronic plc maintains a dominant position that has a broader portfolio of products spanning cardiac rhythm management, structural heart, and coronary interventions. The company is highly concentrated on continuous innovation, including AI-enabled diagnostics and minimally invasive therapies.
• Abbott Laboratories is another key player that is well recognized for its leadership in interventional cardiology and structural heart devices, especially in terms of transcatheter valve therapies. The firm is mainly focused on advancing next-generation technologies and expanding indications for its existing products.
• Boston Scientific Corporation has established a strong presence through its diversified cardiovascular portfolio, which includes electrophysiology, coronary therapies, and peripheral interventions. The company has its main priority towards innovation in less invasive procedures and digital health integration.
• Edwards Lifesciences Corporation is a global leader in structural heart therapies, particularly in terms of transcatheter aortic valve replacement. Besides, the firm’s strategy centers on technological differentiation, strong physician engagement, and expanding access to advanced heart valve therapies across the globe.
• Terumo Corporation is a central player in this field, especially in interventional systems and vascular access solutions. The company benefits from a strong presence in Asia, along with growing penetration in Western markets.